WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year
- Written by PR Newswire
- Ranked among the top 1% of companies assessed in the pharmaceutical industry
- Recognized as a leader in Green CRDMO, driving innovation for a healthier future
- Committed to creating long-term value for all stakeholders
SHANGHAI, Feb. 10, 2025/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and...
